KELSEY HOEHN: Open Payments
NPI 1043882590 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 44 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $574 · 2025 $1,318
Food & beverage: $1,318
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $263 |
| ABBVIE INC. | 6 | $246 |
| AstraZeneca Pharmaceuticals LP | 8 | $183 |
| Genmab U.S., Inc. | 5 | $141 |
| Caris MPI, Inc. | 3 | $138 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Myriad Genetic Laboratories, Inc. | 2 | $64 |
| Eisai Inc. | 2 | $61 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Tempus AI, Inc | 1 | $28 |
Products named: ELAHERE, LYNPARZA, KEYTRUDA, Tivdak, MI CANCER SEEK, MYRISK, Lenvima, JEMPERLI.
Industry payments across MO — which companies pay providers there.
